Events

Recall of Panbio Q Fever IgM ELISA (An in vitro diagnostic medical device (IVD))

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Inverness Medical Innovations Australia Pty Ltd T/A Alere.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2014-RN-01050-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2014-09-30
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-01050-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    The manufacturer’s internal investigations of the lot number listed above have indicated kit degradation during stability monitoring, thus affecting the performance of the kit prior to kit expiry. one customer complaint has also been received relating to this issue. due to the instability of the serum used in manufacturing the positive control and calibrator, the values of positive control, calibrator and cut-off were out of specification. the fluctuating values could lead to a potential risk of false positive/false negative results.
  • Action
    Alere is requesting their customers to immediately discontinue use of this lot and dispose of any remaining affected product and is providing refund for the unused kits. Alere is recommending that a review of the previously reported results be undertaken. Alere is discontinuing this product and requesting the users to investigate an alternative method of testing Q fever. This action has been closed-out on 06/06/2016.

Device

Panbio Q Fever IgM ELISA (An in vitro diagnostic medical device (IVD))

Manufacturer

Inverness Medical Innovations Australia Pty Ltd T/A Alere
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DHTGA